WinstonWınston
Back
Reckitt Benckiser Group logo

Reckitt Benckiser Group

RKT.L
53
Household & Personal Products · Consumer Defensive
Price
5,142.00 GBp
+145.00 (+2.90%)
Market Cap
£32.65B
Exchange
London Stock Exchange
Winston Score
53
Winston is curious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Strong
Growth
Mixed
Cash Flow
Good
Stability
Good
Valuation
Good
Dividends
Exceptional

Share count falling — buybacks

8.4% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 713.8M (2021) → 653.9M (2025)

Winston Score History

The full picture

Reckitt Benckiser is a British consumer goods company that makes health, hygiene, and nutrition products sold in homes around the world. Its brands include Dettol, Lysol, Durex, Nurofen, Strepsils, and Enfamil baby formula. The company sells mainly to everyday consumers through supermarkets, pharmacies, and online retailers.

Reckitt earns money by selling these branded products directly to retailers and distributors, who then sell them to shoppers. It operates in over 60 countries, with strong sales across North America, Europe, and Asia, and generates roughly $15 billion in annual revenue. Its main competitive advantage is its portfolio of trusted, well-known brands in categories where consumers tend to stick with familiar names. The biggest risk the company faces is ongoing legal and financial pressure related to its Enfamil baby formula products, where lawsuits have alleged links to a serious intestinal condition in premature infants, creating significant uncertainty around future costs.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
58.3%
Premium pricing power — 58.3% gross margin
Profit after running costs
Operating Margin
18.2%
Healthy — 18.2% operating margin
Return on the money invested
ROCE
24.9%
Exceptional — 24.9% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-2.5%
Shrinking sales (-2.5% YoY)
Profit growth
EPS YoY
+298.2%
Earnings growing fast (+298.2% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
73%
Modest — 73% of profit becomes cash
Spare cash per sale
FCF Margin
11.3%
Modest free cash flow (11.3%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
1.75
Elevated debt (1.75)
Covers its interest
Interest Cover
8.75x
Comfortably covers interest (8.8x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
11.5x
Attractive valuation — P/E 11.5

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
-1.8
SLOWING
Earnings expected to fall — forward P/E higher than today

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
6.48%
Healthy income — 6.48% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend record
Dividend Growth
+40.8%
Dividend growing fast (40.8% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial